Medical Dermatology
Conference Coverage
Scleroderma SCOT trial findings hold similar in lung disease
CHICAGO –
Conference Coverage
Genetic profile flags scleroderma patients with best HSCT responses
CHICAGO – Gene-expression profiling identifies four scleroderma subgroups, including one subgroup with the best response to stem cell transplant...
Conference Coverage
Ligelizumab outperformed omalizumab for refractory chronic spontaneous urticaria
PARIS – Investigational drug ligelizumab achieved a faster response, higher clearance rate in a phase 2b study.
Conference Coverage
Secukinumab shows promise in hidradenitis suppurativa
PARIS – Strong efficacy in a pilot study underscores the importance of the Th17 pathway in the pathogenesis of this disease.
News
Sandoz halts pursuit of U.S. approval for rituximab biosimilar
Conference Coverage
Experience – not evidence – is best guide in keloid treatment
LAS VEGAS – Surgery is usually not an option, and it may be necessary to convince patients about other treatment options.
Conference Coverage
Investigational agent VT-1161 looks promising for onychomycosis
LAS VEGAS – The oral agent has potent activity against several species of tinea and yeast.
Conference Coverage
Delusional infestation: not so rare
PARIS – Mayo Clinic study shows prevalence climbs sharply with advancing age.
Conference Coverage
Leflunomide-hydroxychloroquine combo shows promise in primary Sjögren’s pilot study
CHICAGO – Randomized, placebo-controlled trial may support evidence for an added benefit of the two drugs together.
Conference Coverage
Serlopitant quells prurigo nodularis in phase 2 study
PARIS – Multiple phase 3 trials are underway for this promising agent.
Conference Coverage
SLE low-disease definition receives prospective validation
CHICAGO – Researchers validated a proposed definition of low disease activity state in lupus patients in a large, prospective, multicenter study...